GSTM1 and type 2 diabetes mellitus: Future studies could attempt to distinguish Hb oxidation products in T2D, possibly via absorbance spectroscopy with spectral deconvolution techniques [26, 50] or via reverse-phase high performance liquid chromatography (RP-HPLC) [34] and quantify their relative proportions.